|
ENTA Enanta Pharmaceuticals Inc 1177648 |
| Balance Sheet |
|
Current Assets
|
$178,412,000.00 |
|
Assets
|
$314,704,000.00 |
|
Current Liabilities
|
$46,442,000.00 |
|
Liabilities
|
$198,117,000.00 |
|
Equity
|
$116,587,000.00 |
|
Shares Out
|
29061000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,855,000.00 |
|
Investing Cash Flow
|
$-35,356,000.00 |
| Market Analysis |
Market Cap
|
$377,793,000.00 |
|
Price
|
$12.61 |
|
BVPS
|
4.01 |
|
PB
|
3.24 |
|
EPS
|
-0.45 |
|
PS
|
6.40 |
|
FCF
|
$-19,013,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:28 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-09 |
-0.42 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-11 |
-0.45 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.85 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-17 |
-0.87 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENTA documents filed with the SEC.
ENTA Filings
Clear
